• Guideline Summary
  • NGC:009318
  • 1996 (revised 2012 Dec 18)

Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.

  • Guideline Summary
  • NGC:011028
  • 2016

ACR Appropriateness Criteria® breast cancer screening.

  • Guideline Summary
  • NGC:011032
  • 2016

ACR Appropriateness Criteria® pretreatment staging of colorectal cancer.

  • Guideline Summary
  • NGC:010848
  • 2015

ACR Appropriateness Criteria® pretreatment planning of invasive cancer of the cervix.

  • Guideline Summary
  • NGC:010172
  • 1999 (revised 2013)

ACR Appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer.

  • Expert Commentary

Colorectal Cancer Guideline Reflects International Practice Variations

  • Guideline Summary
  • NGC:010845
  • 2015

ACR Appropriateness Criteria® renal cell carcinoma staging.

  • Guideline Summary
  • NGC:010653
  • 2014

ACR Appropriateness Criteria® evaluation of the symptomatic male breast.

  • Guideline Summary
  • NGC:011080
  • 2016

ACR Appropriateness Criteria® hematospermia.

  • Guideline Summary
  • NGC:010459
  • 1996 (revised 2014)

ACR Appropriateness Criteria® abnormal vaginal bleeding.

  • Guideline Summary
  • NGC:011021
  • 2016 Jul 6

Non-alcoholic fatty liver disease (NAFLD): assessment and management.

  • Guideline Summary
  • NGC:009660
  • 1996 (revised 2012)

ACR Appropriateness Criteria® radiologic management of inferior vena cava filters.

  • Guideline Summary
  • NGC:010842
  • 2015

ACR Appropriateness Criteria® fever without source or unknown origin — child.

  • Guideline Summary
  • NGC:010165
  • 1996 (revised 2013)

ACR Appropriateness Criteria® post-treatment follow-up of renal cell carcinoma.

  • Guideline Summary
  • NGC:010545
  • 2012 Aug

SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver.